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ABSTRACT 
Dietary supplement (DS) use among adults is on the rise. This growing trend in 
DS use mirrors the quick and exponential growth of the fitness industry. The fitness 
industry focuses on the “appearance of health”, although some individuals focus on their 
appearance over and above their health. As a result of this focus on appearance, certain 
aspects of this unregulated industry promote unhealthy standards of beauty and an 
increase in negative body image, and influences at-risk youth to engage in dangerous 
practices such as extreme diet and exercise routines, or the misuse of dietary 
supplements. All of these factors have been linked to appearance and performance 
enhancing drug use, which is associated with substance use in athletes and non-athletes. 
This study sought to explore the role of gender as it pertained to dietary supplement use, 
specifically how gender differences amongst predictors of DS use (including BMI, 
physical activity, and body image) were associated with overall substance use in college 
students. The relationship between current DS use and other substance use was also 
examined. Students recruited from ASU fitness centers completed a survey which 
included questions on demographics, height and weight to calculate BMI, and several 
published, standardized questionnaires used to measure drug use, physical activity, body 
image, steroid and ephedrine use and attitudes, and dietary supplement use. There were 
significant gender differences in DS use as well as predictors or DS use. Controlling for 
demographic information, energy enhancing DS use and knowing someone who used 
steroids increased the likelihood an individual intended on using steroids in the future. 
Body image was not related to substance use in males, and physical activity mediated the 
relationship between DS use and substance use in males. While body image was 
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associated with substance use in females, neither physical activity nor body image 
mediated the relationship between DS use and substance use in females.  
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INTRODUCTION 
Dietary supplement (DS) use among adults has increased over the past 30 years. In 
the 1980’s, data from the United States Health and Nutrition Examination Surveys 
suggested about a third of the adults in the US were taking some DS regularly (Koplan, 
Annest, Layde & Rubin, 1986; Subar & Block, 1990). In 1994, Congress amended the 
Federal Food, Drug, and Cosmetic Act to establish standards for DS to protect the right 
of access of consumers to safe DS to promote wellness (National Institutes of Health 
[NIH], 1994). The trend continued and by 2011 prevalence rates of DS use fluctuated 
between 64% and 69% (Dickinson, Blatman, El-Dash, & Franco, 2014). 
The U.S. Food and Drug Administration (FDA) defines a DS as, “a product 
intended for ingestion that contains a ‘dietary ingredient’ intended to add further 
nutritional value to (supplement) the diet” (FDA, 2015). DS of all varieties are now 
marketed in the United States, including single-ingredient products and various 
combinations of vitamins, minerals, botanicals, and other constituents. Multivitamins, 
calcium and omega-3’s were the most common supplements reported amongst adults in 
the United States from 2007-2010 (Bailey, Gahche, Miller, Thomas, & Dwyer, 2013). In 
2015, more college students reported taking DS at least once a week than the general 
population (66 vs. 50%), with 41% reporting taking multiple supplements (Lieberman, et 
al., 2015). The most commonly DS used by students include vitamins, protein or amino 
acids, and herbal products (Hildebrandt, Harty, & Langenbucher, 2010). Students take 
DS to promote health, provide energy, and increase muscle strength, endurance and 
performance (Lieberman, et al., 2015). Only 23% of adults reported using supplements 
per the recommendation of a health care professional (Bailey et al., 2013).  
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This growing trend in DS use mirrors the quick and exponential growth of the 
fitness industry (Andreasson & Johansson, 2014). From 2005 to 2015, health club 
memberships increased from 41.3 million to 55.3 million, and the number of health clubs 
increased from 26,000 to 36,000 (International Health, Racquet & Sportsclub 
Association, 2016). To achieve this level of growth the health and fitness industry 
became a business enterprise targeting aesthetically conscious consumers (Smith-
Maguire, 2008). The annual survey of worldwide fitness trends found that body weight 
training was considered the number 1 fitness trend in 2015, and the number 2 fitness 
trend in 2016 (Thompson, 2016). The development of a global gym and fitness culture 
has been accentuated by mediatization blurring the relationship between health and 
beauty (Andreasson & Johansson, 2014). For example, the term “fitsporation,” short for 
Fitness Inspiration, is flooding social media platforms, encouraging followers to find 
inspiration to attend the gym (Carrotte, Vella & Lim, 2015). While a majority of these 
“fitspiration” posts contain images of people, some also contain text, or images of food or 
DS (Santarossa, Coyne, Lisinski & Woodruff, 2016). These posts are supposedly meant 
to promote health and fitness, however the content provided has been shown to be 
associated with at-risk youth engaging in dangerous practices, including extreme diet and 
exercise routines, and misuse of weight loss supplements (Carrotte, et al., 2015). These 
dangerous practices might have damaging, long-term health and psychological 
consequences including unhealthy standards of beauty and an increase in negative body 
image (Boepple & Thompson, 2016; Ghaznavi & Taylor, 2015; Lewallen & Behm-
Morawitz, 2016; Tiggemann & Zaccardo, 2015).  
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Those new to the fitness industry can also reach for magazines such as Men’s 
Health, Women’s Health, Shape, or Muscle and Fitness, which are filled with images of 
muscular males and toned females, along with advertisements for muscle-building and 
weight-loss supplements (Figure 1; Wasylkiw, Emms, Meuse, Poirier, 2009). Historically 
magazines popular among young women contained 10.5 times more pieces (ads and 
articles) promoting weight loss as the men's magazines (p <.005); while young men’s 
magazines disproportionately contained (p <.01) messages on body shaping compared to 
weight loss (Andersen 1992). Recently, Willis and Knobloch-Westerwick (2014) 
reported health and fitness magazines such as Women’s Health have become the main 
source of weight-loss and body-shaping messages, and have taken the market away from 
the traditional beauty, fashion, or general interest magazines. In their analysis, the authors 
found that the messages in the health and fitness magazines emphasized appearance and 
exercise with approximately one-fifth of all editorial content dedicated to messages 
emphasizing body-shaping and weight-loss. Furthermore, recent evidence (Bazzini, 
Pepper, Swofford and Cochran, 2015; Stevens-Aubrey and Hahn, 2016) suggests that 
health and fitness magazines have an increased focus on appearance rather than overall 
health, particularly those with women readership. While the increased focus on fitness 
may help with the growing rate of obesity in the U.S. (Dunlop, et al., 2016; Flegal, 
Kruszon-Moran, Carroll, Fryar & Ogden, 2016; National Center for Health Statistics, 
2015), potentially dangerous results of this emphasis are also of concern (Austin, 2011). 
For example, 34.7% of adolescents surveyed reported using protein powders or shakes 
and 5.9% reported steroid use (Eisenberg, et al., 2012). Excess body weight (BMI>25) 
and participation in team sports have been associated with muscle-enhancing behaviors 
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(Eisenberg, et al., 2012). Similarly, Hoffman found that people who use DS and anabolic-
androgenic steroids (AAS) exercise more than non-users, and their exercise tends to be 
more intense (Hoffman, et al., 2008). 
In addition, there is evidence that exposure to extreme body types in popular 
media has detrimental effects in both young females and males (Peixoto-Labre, 2002; 
Raevuori, Keski-Rahkonen, Bulik, Rose, Rissanen, & Kaprio, 2006; Arbour, & Martin-
Ginis, 2005; Cramblitt & Pritchard, 2013; Hildebrandt, et al., 2006; Field et al., 1999; 
Hawkins, et al., 2004; Duggan & McCreary, 2004). Exposure to images of severely thin 
female models has been shown to increase the risk for bulimia and anorexia nervosa and 
has also been associated to high levels of body dissatisfaction (Field et al., 1999; 
Hawkins, Richards, Granley & Stein, 2004; Boepple & Thompson, 2016; Holland & 
Tiggemann, 2017). Further, media exposure to extreme body types showed negative 
long-term effects on women with low levels of social support, who were already at a 
higher risk of negative body-image, leading researchers to believe that messages seen in 
the media may reinforce the messages in one’s immediate social environment (Stice, 
Spangler & Agras, 2001).  
Research looking at the influence of media on males has focused more on the 
muscular body-ideal (Peixoto-Labre, 2002; Raevuori, Keski-Rahkonen, Bulik, Rose, 
Rissanen, & Kaprio, 2006; Arbour, & Martin-Ginis, 2005; Cramblitt & Pritchard, 2013; 
Hildebrandt, et al., 2006). For example, Cramblitt & Pritchard (2013) found that reading 
men’s health magazines and watching image-focused television led to a greater drive for 
muscularity in men. Similar results were seen in a study looking at homosexual men, 
which showed that greater consumption of fitness magazines correlated with higher 
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scores in body dissatisfaction (Duggan & McCreary, 2004). Furthermore, there is 
evidence that exposure to images of hyper-muscular males in the media is associated to 
an increase in binge eating (Peixoto-Labre, 2002), bulimia (Raevuori, Keski-Rahkonen, 
Bulik, Rose, Rissanen, & Kaprio, 2006), as well as higher levels of muscle dissatisfaction 
(Arbour, & Martin-Ginis, 2005; Cramblitt & Pritchard, 2013; Peixoto-Labre, 2002). In 
addition, high levels of muscle dissatisfaction significantly correlated with bulimia in 
men (Raevuori et al. 2006). It is not clear if exposure to images of hyper-muscular males 
increases body dysmorphic disorders (BDD), if the relationship is bi-directional, or if 
BDD precede the exposure to fitness magazines (Shoger, 2008; Krawiec, 2016; Peixoto-
Labre, 2004). BDD is characterized by a distressing or impairing preoccupation with 
slight or imagined defect(s) in one's physical appearance, with estimates ranging between 
2-13% among college students (Bjornsson, Didie, & Phillips, 2010). Muscle dysmorphia 
is a type of BDD with a focus on feelings of inadequacy regarding the size of lean muscle 
mass, despite already being muscular (Hagerman, Dawes, & Mankin, 2004). This form of 
BDD in particular seems to be growing among male athletes, bodybuilders and 
weightlifters (Peixoto-Labre, 2002; Hildebrandt, et al., 2006; Pope, Khalsa, & Bhasin, 
2017; Leone, Sedory, & Gray, 2005).  Some males are going to extremes to achieve a 
particularly muscular look, which include taking untested supplements or appearance and 
performance enhancing drugs (APED), and/or engaging in extreme dieting that can lead 
to serious eating disorders (Melki, Hitti, Oghia, & Mufarrij, 2015; Peixoto-Labre, 2002; 
Raevuori, Keski-Rahkonen, Bulik, Rose, Rissanen, & Kaprio, 2006; Arbour, & Martin-
Ginis, 2005; Cramblitt & Pritchard, 2013; Hildebrandt, Schlundt, Langenbucher & 
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Chung, 2006). These unhealthy practices have been shown to have severe long-term 
health consequences (Leone, Sedory, & Gray, 2005).  
Researchers comparing body image dissatisfaction between males and females 
have found that dissatisfaction in females is characterized by a desire to lose weight 
(Kelley, Neufeld, & Musher-Eizenman, 2010; Furnham, Silberstein, Abell, 2002; 
Silberstein, Striegel-Moore, Timko, & Rodin, 1988; Abell & Richards, 1996), while body 
dissatisfaction for males seems to be split between a desire to lose weight and a desire to 
gain weight through an increase in lean muscle mass (Kelley, et al., 2010; Arbour, & 
Martin-Ginis, 2005; Cramblitt & Pritchard, 2013; Peixoto-Labre, 2002; Furnham, 
Silberstein, Abell, 2002; Silberstein, et al., 1988; Abell & Richards, 1996). For example, 
Furnham et al. (2002) found strikingly high levels of body dissatisfaction among 
adolescents, with only 21.1% of the boys and 18.3% of the girls reporting satisfaction 
with their body image (Contour Drawing Rating Scale [CDRS] score of 0). Interestingly, 
they also found a significant difference in the direction of their dissatisfaction with 36.1% 
of the males wanting to lose weight and 42.8% of the males wanting to become bigger, 
compared to only 8.1% of the females desiring to be bigger and 74.6% wanting smaller 
frame. It is important to note, though, that a drive for thinness and a drive for muscularity 
are not mutually exclusive, and should not be looked at as a continuum (Kelley, et al., 
2010; Eisenberg, Wall, & Neumark-Sztainer, 2012; Cramblitt & Pritchard, 2013). In fact, 
a recent study found that women who regularly post fitness related images on social 
media scored higher on both drive for thinness and drive for muscularity (Holland & 
Tiggemann, 2017).  
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It has been proposed that the underlying mechanism driving the relationship 
between what is seen on social media and the attitudes and behaviors of individuals is 
rooted in social learning (Peixoto-Labre, 2002; Bandura, 2001).  
According to Bandura (2001), humans are capable of observational learning, 
meaning they do not have to directly experience an event in order to learn from it; this is 
the proposed mechanism through which mass media influence behavior (Bandura, 2001; 
Bandura, 2002). While the mass media has been shown to shape people’s beliefs, people 
are also greatly influenced by the behaviors and actions of others through social 
prompting (Bandura, 2001; Bandura, 2002). Modeling not only influences our behaviors, 
but outcomes from these observed behaviors can serve as an incentive or disincentive by 
creating a reference point for social comparison (Bandura, 2001; Bandura 2002).  
In addition, Bandura’s (2001) Social Cognitive Theory (SCT) characterizes 
human as knowers, performers, and self-managers of their own behaviors and 
environment; who are embedded in complex social systems. Hence, human psychosocial 
functioning is the result of “cognitive, affective, and biological events, behavioral 
patterns, and environmental events all operat[ing] as interacting determinants that 
influence each other bidirectionally” (p. 266). One maintains self-motivation through 
internal standards and evaluative reactions to one’s own behavior. Substandard self-
evaluated performances provide the negative feedback and motivation for a new action 
toward achieving the behavior to be mastered.  
According to Peixoto-Labre (2002), young males engage in social comparison by 
utilizing images of other men in fitness and bodybuilding media as points of reference for 
what is socially desirable. They are then motivated by this comparison to engage in 
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similar behaviors, both healthy and dangerous, in order to obtain this desired, muscular 
body-type (Melki, et al., 2015; Peixoto-Labre, 2002; Eisenberg, et al., 2012; Frison, 
Vandenbosch & Eggermont, 2013).  
The food and beverage industry effectively applies these principles using various 
print and social media to market products to young adults (Freeman, et al., 2014), 
including products that negatively influence health behaviors (Dunlop, Freeman, & 
Jones, 2016). The DS marketed to young adults through ads in social media outlets and 
popular magazines can mislead consumers, placing these products next to images of 
individuals who have potentially obtained their build through practices other than taking 
these supplements (see Figure 1).  
In addition to the negative behavioral and psychological consequences, such as 
unrealistic and/or unhealthy standards of beauty, the availability and aggressive 
marketing of DS presents a very real and dangerous risk to the health of consumers. This 
health risk for consumers arises from the lax rules regarding food labeling, because some 
products marketed as DS may contain ingredients, specifically steroids, not listed on the 
product packaging (Abbate, et al., 2014). Further, both males and females have been 
shown to pursue potentially dangerous muscle-enhancing behaviors (Clark & Henderson, 
2003; Eisenberg, et al., 2012; Frison, et al., 2013) including DS misuse. The 
consequences of misguided chronic overuse of DS may lead to wasteful spending at a 
minimum (Lieberman, et al., 2015), but could also lead to more serious adverse health 
effects such as insomnia, vomiting, gastrointestinal bleeding, impaired renal function and 
deteriorated bone health (Barzel & Massey, 1998; Maughan, King & Lea, 2004; Stickel, 
Kessebohm, Weimann & Seitz, 2011; Thorsteinsdottir, Grande & Garovic, 2006). The 
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risk of side effects is the same for individuals who use DS for their general health and 
well-being as for individuals who use DS to improve their performance in sports or to 
improve their appearance for bodybuilding competitions (Navarro, et al., 2014).  
Consumption of DS has been associated to the consumption of many other 
potentially dangerous substances (Raevuori, et al., 2006; Yager and O’Dea, 2014; 
Backhouse, et al., 2013; Hildebrandt, et al., 2010; Hoffman, Faigenbaum, Ratamess, 
Ross, Kang & Tenenbaum, 2008; Buckman, Farris & Yusko, 2013). For example, higher 
use of DS correlates with higher rates of steroid use and higher levels of muscle 
dissatisfaction in males (Raevuori, et al., 2006; Yager and O’Dea, 2014). Similarly, 
Backhouse, et al. (2013) found that DS users consumed more substances that are banned 
by World Anti-Doping Agency (WADA), had more positive beliefs about using banned 
APEDs, and were more willing to take a substance to both improve their performance 
and their appearance. This pattern has also been observed among college students, with 
research showing that both athletes and non-athletes who use DS are more likely to use or 
intend on using AAS (Hildebrandt, et al., 2010; Yager & O’Dea, 2014; Backhouse, et al., 
2013; Hoffman, et al., 2008; Buckman, et al., 2013).  
APEDs are substances used to improve one’s appearance as well as athletic or 
physical performance (Hildebrandt, Lai, Langenbucker, Schneider, Yehuda & Pfaff, 
2011; Hildebrandt, Langenbucher, Carr, & Sanjun, 2007). APED is an umbrella term for 
substances that build up muscle, such as AAS or human growth hormone, or reduce body 
fat, such as thyroid hormones, beta-2 agonists (e.g. clenbuterol), and central nervous 
system stimulants (e.g. ephedra) (Hildebrandt, 2007).  
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AAS are synthetic variations of testosterone (Drug Enforcement Administration 
[DEA], 2004; McDuff & Baron, 2005); anabolic refers to tissue building, and androgenic 
refers to the promotion of masculine characteristics (DEA, 2004; Clark & Henderson, 
2003). They can be ingested in pill form, or injected with a syringe (DEA, 2004; 
Parkinson & Evans, 2006). AAS can also be applied to the skin like a cream (DEA, 
2004); this method is utilized by many athletes to avoid positive drug test results (Bahrke 
& Yesalis, 2004). Steroid abusers follow patterns of use described as “stacking” and 
“cycling”; that is an abuser will use two or more steroids at a time (stacking), and will 
going through periods of use followed by periods of low or non-use (cycling) (DEA, 
2004; Maravelias, Dona, Stefanidou, & Spiliopoulou, 2005; Parkinson & Evans, 2006).  
APEDS have both positive and negative side effects – while they can improve one’s 
performance and appearance (Clark & Henderson, 2003; Bahrke & Yesalis, 2004; 
Hildebrandt, 2007; Parkinson, & Evans, 2006; McDuff & Baron, 2005), they are also 
linked to altered reproductive and hepatic function, and have been shown to alter cardiac 
structure (Thiblin, Mobini-Far & Frisk, 2009; Hildebrandt, 2007; Clark & Henderson, 
2003; Maravelias, et al., 2005). Although the use and distribution of certain APEDs, like 
ephedra, are illegal, other products containing similar chemical structures to ephedra have 
been created and sold as weight loss or performance enhancement supplements (McDuff 
& Baron, 2005). These items are utilized for the same purposes as the illegal substances, 
and cause many of the same side effects (McDuff & Baron, 2005). The same patterns can 
be seen in AAS use. To circumvent laws banning the sale to the public of prescription 
steroids (McDuff & Baron, 2005), many steroid-like supplements are legally sold in the 
U.S. with components such as testosterone precursors or prohormones, which are 
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chemically modified versions of illegal steroids (Rahnema, Crosnoe & Kim, 2014; 
McDuff & Baron, 2005; Rahnema, et al., 2014) with similar effects and side-effects as 
AAS (Rahnema, et al., 2014).  
Side effects of AAS abuse include acne, high cholesterol, hypogonadism and fluid 
retention, and psychological side effects such as hostility, depression, and mood swings 
(Clark & Henderson, 2003; Bahrke & Yesalis, 2004; Maravelias, et al., 2005; Parkinson 
& Evans, 2006; Rahnema, et al, 2014; Coward, Rajanahally, Kovac, Smith, Pastuszak & 
Lipshultz, 2013; McDuff & Baron, 2005). While most side effects may be reversible, 
others, such as the masculinizing effects seen in women, are not (DEA, 2004).  
While there is some contending evidence that APED use in athletes is decreasing 
(Hoffman, et al., 2008), other research suggests that both legal and illegal APED use may 
be actually on the rise (McCabe, Brower, West, Nelson & Wechsler, 2007; Hoyt, Albert 
& Heard, 2013) due to pressures to perform and the allure of fame and fortune that comes 
with success (Ehrnborg & Rosen, 2009; Wood, 2008).  
In addition to its association to DS use, there is also evidence suggesting AAS use 
may be associated to other substance use, including heroin, cocaine and tobacco (DuRant, 
Escobedo & Health, 1995; Buckman, et al., 2013; McDuff & Baron, 2005; McCabe, et 
al., 2007; Kanayama, Pope, Cohane, & Hudson, 2003); which is of great concern given 
the evidence that substance use in general (i.e., alcohol, marijuana, amphetamines, 
tobacco, and narcotics) is widespread amongst athletes (Green, Uryasz, Petr & Bray, 
2001; McDuff & Baron, 2005; Buckman, et al., 2013; McCabe, et al., 2007; Buckman, 
Yusko, White & Pandina, 2009; Lisha & Sussman, 2010). For example, alcohol 
consumption and binge drinking is greater in athletes than non-athletes, with 75% - 93% 
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of athletes reporting alcohol use compared to 75% -80% of non-athletes (Lisha & 
Sussman, 2010; McDuff & Baron, 2005).  
While steroid use has been studied in athletes (Eisenberg, et al., 2012; Ehrnborg & 
Rosen, 2009; Hildebrandt, et al., 2010; Yager & O’Dea, 2014; Backhouse, et al., 2013; 
Hoffman, et al., 2008; McDuff & Baron, 2005; Buckman, et al., 2013), there is evidence 
that APED and AAS use for aesthetic purposes amongst college students and gym-goers 
is also increasing (Hoyt, Albert & Heard, 2013; Parkinson & Evans, 2006; Ehrnborg & 
Rosen, 2009; Rahnema, et al., 2014- Fertility and Sterility; Lippi, Franchini & Guidi, 
2008). The increase in APED use is seen in both men and women (Bahrke & Yesalis, 
2004; Thiblin, et al., 2009) and a wide age range, from high school students to middle-
aged individuals (Coward, et al., 2013). APED use is more commonly reported amongst 
male weight lifters (Kanayama, Pope, Cohane, & Hudson, 2003; Pope, Kanayama, & 
Hudson, 2012), and has been linked to negative body image (Coward, et al., 2013; 
Ehrnborg & Rosen, 2009; Kanayama, et al., 2003; Pope, et al., 2012), and conduct 
disorders (Pope, et al., 2012). Individuals who are interested in using APEDs can not only 
buy many of these substances online without a prescription, but can also find out 
information on administering, cycling and stacking these substances online (Parkinson & 
Evans, 2006; Brennan, Kanayama & Pope, 2013). 
DS currently on the market do not have to be tested or approved for safety and 
effectiveness by the FDA (Dodge, Litt & Kaufman, 2011); but the FDA is responsible for 
removing products from the market once harmful side-effects are reported (Dodge, Litt & 
Kaufman, 2011; Government Accountability Office, 2013). Individuals may be motivated 
to take DS in order to improve their athletic performance (Schwenk and Costley, 2002), 
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an unproven benefit commonly used for marketing purposes (Molinero and Marquez, 
2009; Williams, 2006). In fact, knowledge of the safety or efficacy of DS use does not 
seem to affect the amount of DS used, whether it be for aesthetic or performance 
purposes. When looking specifically at elite athletes, for example, higher DS use is seen 
in athletes at higher levels of performance, and in athletes who compete in individual 
sports as opposed to team sports (Giannopoulou, Nautsos, Apostolidis, Bayios and 
Nassis, 2013).  
Unfortunately, knowing that a product had received (or not) FDA approval (i.e., 
information alone) does not seem to impact consumers’ beliefs. In an experimental 
condition, Dodge et al. (2011) found that knowing whether or not the FDA had approved 
a product did not influence participants’ ratings of safety or effectiveness of a DS.  
Popular media’s focus on the fitness industry has increased young adults’ motivation 
to obtain a very specific body type, leading to various dangerous muscle-building and 
weight-loss behaviors. The purpose of this study was to examine the relationships 
between substance use (including DS, APED and other substances), body image, and 
physical activity (including participation in sport, regular exercise and weight lifting), to 
see if gender affects these relationships, and to identify which of these variables act as 
protective or risk factors. 
Because previous research has found gender differences in DS use, this study will look at 
gender differences in APED use and factors related to APED use in a population of 
young adults.  
H1A: There are significant gender differences in physical activity, BMI, dietary 
supplement use, ephedrine use, steroid use, and intent on using steroids. 
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H1B: There are significant gender differences in scores on body image, which will 
have an effect on physical activity, dietary supplement use, ephedrine use, steroid use, 
and intent on using steroids in the future. 
Exposure to the fitness culture through popular media has been shown to lead to an 
increase in APED use, particularly AAS use. Hypothesis 2 will look at AAS use and 
variables related to fitness. 
H2: Dietary supplement use, substance use, BMI, physical activity, participation in a 
sport and knowing someone who uses steroids will increase the risk of someone using 
steroids in the future. The relationships will vary by gender.  
Because previous findings have shown a relationship between DS use and substance use, 
hypothesis 3 will look whether there are any potential mediators in this relationship.  
H3: Physical activity will mediate the relationship between DS use and substance use, 
and this relationship will be moderated by body image. The relationships will vary by 
gender. 
METHODS 
Participants 
Participants were ASU students between the ages of 18 and 34 who had 
participated in some sort of physical activity at least once per week, outside of the job or 
housework. Looking to enroll more health-conscious individuals, participants were 
recruited from Sun Devil Fitness Facilities. Participants in this study had similar median 
BMIs, 23.02 vs 23.36, but reported higher use of DS than a sample of students in the 
psychology program (Bucko, Velez-Bermudez, Hartman, Mills, Vargas, 2016; Lara, 
Altholz, Flores, Jackson, Vargas, 2013).  The listserv included 70,872 students who have 
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used the Sun Devil Fitness Centers facilities at any of ASU four campuses. Students in 
the listserv received two email invitations to complete an online survey. The study was 
approved by Arizona State University’s Institutional Review Board.  
Procedure 
Data were collected online through Surveymonkey.com. Participants (n = 667) 
read a description of the study and gave passive consent by continuing to complete the 
survey. Students who completed the survey were entered into a raffle to win 1 of 50 $10 
electronic VISA gift cards. The survey included questions on demographics, height and 
weight to calculate BMI, and several published, standardized questionnaires used to 
measure drug use, physical activity, body image, steroid and ephedrine use, and dietary 
supplement attitudes and use. Completing the survey took approximately 45 minutes. 
Measures 
 The College Student Supplement Survey included questions to assess patterns of 
physical activity (PA) including aerobic PA, and weight lifting, body image, and patterns 
of dietary supplements, steroid and other drug use. Skip patterns were included to allow 
respondents to skip over non-applicable questions. For example, participants were asked, 
“Have you ever used any of the following items or substances? Cigarettes/Tobacco; 
Alcohol; Marijuana; Synthetic marijuana.” Students who answered, “No” or “Prefer not 
to answer”, received a score of 0 on all questions related to cigarettes/tobacco, alcohol, 
marijuana, and synthetic marijuana use, without having to select these options 
themselves.  
Body Mass Index (BMI) was calculated using the formula: weight (in pounds) / 
[height (in inches)]2 x 703 (Center for Disease Control and Prevention [CDC], 2015). 
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While BMI does not measure body fat specifically, it is correlated with other body fat 
measures such as skinfold thickness measurements, as well as metabolic diseases 
associates with body fatness (CDC, 2015). Anyone with a BMI below 18.5 is considered 
underweight; 18.5-24.9 is considered normal weight; 25-29.9 is considered overweight; 
and 30 and above is considered obese.  
Weight lifting physical activity and reasons for lifting weights were also evaluated 
using questions from the Michigan Weight Lifter’s Survey (Brower, et al., 1994; Dunn, et 
al., 2009). Participants were asked, “Do you lift weights as a part of your fitness 
routine?” Participants who indicated that they lifted weights as part of their fitness 
routine were asked about the amount of time they spent each week performing weight 
lifting physical activity by asking “How many hours do you spend each week lifting 
weights?” Participants who previously indicated they did not lift weights as part of their 
fitness routine received a score of 0.  
Aerobic physical activity was evaluated using the questions from the Behavioral 
Risk Factor Surveillance System (BRFSS) (CDC, 2011) following the guidelines created 
by the CDC to measure both moderate and vigorous physical activity in adults. 
Participants were asked, “We are interested in two types of physical activity vigorous and 
moderate. Vigorous activities cause large increases of breathing and heart rate while 
moderate cause small increases in breathing and heart rate. Do not include any time spent 
weight training in your total times. If you did not engage in moderate physical activity, 
select 0. If you did not engage in vigorous physical activity, select 0. If you prefer not to 
answer this question, select 0. The amount of time you spent in each type of physical 
activities or exercises would include... ?” Participants indicated how many days per week 
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and minutes per day they performed moderate and vigorous physical activity. The 
amount of minutes spent per day on each type of aerobic physical activity was multiplied 
by the amount of days per week spent on each type of physical activity to obtain the 
amount of minutes per week spent on each type of physical activity. The values 
calculated for minutes per week of moderate aerobic physical activity and minutes per 
week of vigorous aerobic physical activity were added together to calculate the total 
amount of minutes spent per week on aerobic physical activity, and this value was 
divided by 60 to obtain the number of hours spent each week on aerobic physical activity. 
Total amount of physical activity. Total hours spent performing aerobic physical 
activity per week and weight lifting physical activity per week were summed to obtain 
the total amount of hours spent performing physical activity per week.  
 Participation in organized sports. Participants were asked whether or not they 
played for an organized sports team. Those who answered yes selected at which level 
they played at, “For my university team”, “For an on-campus intramural team”, “For an 
off-campus club team”. Because there were no significant differences in DS use, PA, and 
body image, substance use and BMI between the different levels (p < .05), this variable 
was recoded into a binary variable.  
Dietary supplement use. Supplement use was assessed using a modified version of 
the Dietary Supplement and Caffeine Intake Survey of US Army Active-Duty Personnel 
(Carvey, Farina & Lieberman, 2012). Students were asked if they had used supplements 
in the past 30 days; those who had use DS were asked to indicate, from a list of thirty-two 
dietary supplements related to general health (GHDS), which supplements they have used 
in the past month by selecting how often they took them: Never, Once a month, Once a 
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week, 2-3 times per week, 4-5 times per week, 6 times per week, Daily, or Two or more 
times per week. This was also the case for seventeen weight loss dietary supplements 
(WLDS), twenty-two muscle building dietary supplements (MBDS), and fourteen energy 
enhancing dietary supplements (EEDS). A score for each supplement type was calculated 
by adding one point for each specific DS category used, and adding points for frequency 
of used (e.g. 0 - Never, 1 - Once a month, 2 - Once a week, 3 - 2-3 times per week, 4 - 4-
5 times per week, 5 - 6 times per week, 7 - Daily, or 8 - Two or more times per week) 
(ranges: GHDS: 0-256 ; WLDS: 0-136 ; MBDS: 0-176; EEDS: 0-112) A 30-day dietary 
supplement use score was created by summing the scores for all of the supplement types 
(range: 0 - 227).  
Steroid and ephedrine use and attitudes. Steroid use and attitudes were assessed 
using three yes or no questions from the Michigan Weight Lifter’s Survey (Brower, Blow, 
& Hill, 1994; Dunn, et al., 2009). Participants were asked, “Have you ever used steroids 
for training purposes?”; “Would you ever consider using steroids in the future?”; “Do 
you know someone who uses steroids?” Ephedrine use was assessed using a yes or no 
question from section 3 of the National Collegiate Athletic Association Study of 
Substance Use of College Student-Athletes (DeHass, 2006): “Have you ever used 
ephedrine (Ephedra or Ma Huang) for training purposes?” Participants could select, 
“Yes” and receive a score of 1, “No” and receive a score of 0, or “Prefer not to answer”, 
which was coded as missing data.   
Lifetime substance use. Use of drugs, tobacco, alcohol and other substances was 
assessed using the 2017 State and Local Youth Risk Behavior Survey (CDC, 2017). 
Lifetime substance use scores were calculated by asking students, “Have you ever 
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tried/used” for the following items: cigarettes; electronic vapor products; other tobacco 
products; cigars/cigarillos/little cigars; alcohol; marijuana; synthetic marijuana; 
amphetamines; ecstasy (MDMA); psychedelics; crack/cocaine; heroin; 
methamphetamines; prescription medication (without legal a prescription); intravenous 
drugs. Participants who said yes scored a 1 and those who said no scored a 0 for each of 
the items. Data for participants who selected “Prefer not to answer” was coded as 
missing. A score for lifetime substance use was calculated by adding these items, the 
scores ranged from 0 to 15.  
30-Day substance use. Scores for 30-day (current) substance use were calculated 
by asking, “During the past 30 days, on how many days did you use” for the following 
items: electronic vapor products; other tobacco products; cigars/cigarillos/little cigars; 
marijuana; synthetic marijuana; amphetamines; ecstasy (MDMA); psychedelics; 
crack/cocaine; heroin; methamphetamines; prescription medication (without legal a 
prescription); intravenous drugs. Participants who choose “Never used”, or “Have used, 
but not in the past 30 days” scored 0. Data for participants who selected “Prefer not to 
answer” was coded as missing. Otherwise, participants could select “1 or 2 days” (1), “3 
to 5 days” (2), “6 to 9 days” (3), “10 to 19 days” (4) “20 to 29 days” (5) or “All 30 days” 
(6). Possible scores for each of these individual items ranged from 0-6. Scores for 30-day 
cigarette use were calculated by multiplying the amount of days participants reported 
smoking cigarettes in the past 30 days [“0 days” (0), “1 or 2 days” (1), “3 to 5 days” (2), 
“6 to 9 days” (3), “10 to 19 days” (4) “20 to 29 days” (5) or “All 30 days” (6)] by the 
amount of cigarettes smoked per day [“Less than 1 cigarette per day” (0), “1 cigarette per 
day” (1), “2 to 5 cigarettes per day” (2), “6 to 10 cigarettes per day” (3), “11 to 20 
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cigarettes per day” (4), “More than 20 cigarettes per day” (5)]. Data for participants who 
selected “Prefer not to answer” for either or both of these two questions was coded as 
missing. Possible scores for 30-day cigarette use ranged from 0-30. Scores for 30-day 
alcohol use were calculated by multiplying the amount of days participants reported 
drinking alcohol in the past 30 days [“1 or 2 days” (1), “3 to 5 days” (2), “6 to 9 days” 
(3), “10 to 19 days” (4) “20 to 29 days” (5) or “All 30 days” (6)] by the amount of days 
students reported binge drinking, that is having 4 or more drinks in a row for females or 5 
or more drinks in a row for males [“0 days” (0), “1 day” (1), “2 days” (2), “3 to 5 days” 
(3), “6 to 9 days” (4), “10 to 19 days” (5), “20 or more days” (6)]. Data for participants 
who selected “Prefer not to answer” for either or both of these questions were coded as 
missing. Possible scores for 30-day alcohol use ranged from 0-36. A total score for 30-
day substance use was calculated by summing the score of each of these 15 items, 
creating a 30-day substance use score (range: 0-144).  
Body Image attitudes were assessed using the Contour Drawing Rating Scale 
(CDRS) (Thompson & Gray, 1995). Participants were shown the image in Figure 2. 
Females used the nine figures at the top of the scale, and males used the nine figures at 
the bottom of the scale. The numbers 1-17 listed below each of the rows represented body 
sizes, with larger sizes representing the larger body types. Participants first replied to the 
question, “Select the value that is closest to your present size. That is, the size you are at 
the moment”. The value that was selected for the second question, “Select the value that 
is closest to the size you would like to be”, was subtracted from their first answer. 
Negative scores reflected a desire to be bigger, while positive scores reflected a desire to 
be smaller.  A larger absolute value meant that there was a greater discrepancy between 
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what a participant thought their body looked like versus what they wanted their body to 
look like, meaning a greater CDRS scores reflected greater body dissatisfaction. 
Therefore, CDRS scores were recoded into magnitude scores as well (range: 0-16).  
Missing data 
Only 10 students refused to answer questions regarding steroid use; however, 
there were significant differences in lifetime, and 30-day substance use scores between 
those who responded and those who did not respond to questions related to ephedrine 
use, steroid use steroid use intent and knowing someone who uses steroids. These 
differences can be seen in Table 1. Therefore, participants who selected “prefer not to 
answer” for ephedrine use (n = 3) and steroid use (n = 2) steroid use intent (N = 10) and 
knowing someone who uses steroids (n = 6) were excluded from analyses testing 
hypothesis 1, and participants who selected “prefer not to answer” for steroid use intent 
(n = 10) and knowing someone who uses steroids (n = 6) were excluded from analyses 
testing hypothesis 2. 
Data from fourteen students who selected “Prefer not to answer” for one or both 
of the two initial branching questions related to substance use (i.e. Have you ever used 
any of the following items or substances? Cigarettes/Tobacco, Alcohol, Marijuana, 
Synthetic marijuana; Have you ever used any of the following items or substances? 
Amphetamines, Ecstasy (MDMA), Psychedelics, Crack/Cocaine, Heroin, 
Methamphetamines, Prescription Medication (without legal a prescription), Intravenous 
drugs) were deleted. Twelve participants did not fully answer questions related to 30-day 
and lifetime substance use, and were excluded from analyses testing hypothesis 2 and 3.  
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Data Analysis 
 Statistical analysis was conducted using SPSS Statistics for Macintosh, Version 
23.0 (IBM Corp, 2015). Means, standard deviations, modes, medians, and frequencies 
were calculated. Gender differences were tested using t-tests for continuous variables; the 
alpha level was .05. All tests were two-tailed; we did not correct for multiple 
comparisons. The relationships between variables in hypothesis 1 were tested using linear 
and logistic regression analyses. Hierarchical linear regression was used to measure 
steroid use intent in hypothesis 2. The mediated moderation was tested using the Process 
macro for SPSS version 2.16 (Hayes, 2013). Thus, effect sizes are reported as odds ratios 
for logistic regressions.  
RESULTS 
Participants 
The mean age of participants was 20.6 ± 2.8 years with a mean BMI of 23.8 ± 4.5.  
A majority of students (61.8%) were within the normal weight range (BMI, 18.5-24.9 
kg/m2). More than half (57.0%) of the students (N = 667) were female. All students 
reported performing some form of aerobic exercise, and 64.2% of students lifted weights 
as part of their fitness routine. Nearly one third (30.1%) of students reported some current 
DS use (in the past 30 days), with 20.3% of females and 43.2% of males reporting current 
DS use. More than half (59.7%) of the participants reported substance use in the past 30 
days, and two-thirds (66.4%) reported some form of substance use in their lifetime (Table 
2). 
H1A: There are significant gender differences in physical activity, BMI, DS use, ephedrine 
use, steroid use, and intent on using steroids. 
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As Table 2 shows, there were significant differences between males and females. 
Males spent significantly more time performing physical activity overall than females, 
t(665) = 10.00, p < .001; this was the case for both lifting weights, (p < .001), and 
performing aerobic physical activity, (p = .003).  
The 30 - day DS use score had a mean of 17.48 ± 35.00. Males used significantly 
more of all DS types (30-day use scores) than females (p < .001); including DS for 
general health (GHDS) (p = .001), weight loss (WLDS) (p =.001), muscle building 
(MBDS) (p < .001), and energy enhancement (EEDS) (p < .001). The 30 - day substance 
use score had a median of 2 and ranged from 0 to 38, and lifetime substance use had a 
median of 2 and ranged from 0 to 13. Compared to females, males also reported 
significantly more lifetime substance-use (p < .001), as well as current substance use (30-
day, p < .001) (Table 2). Correlations for total physical activity, BMI, total DS use, 
lifetime ephedrine use, lifetime steroid use, intent on using steroids, and CDRS 
magnitude scores can be seen in Table 3. 
Greater BMI predicted greater EEDS use (F(1, 285) = 5.36, p = .02) in males, and 
greater WLDS use in females (F(1, 378) = 5.89, p = .02). Sixty-six percent of the females 
who took dietary supplements had a BMI in the category of normal weight or 
underweight. In males, a greater BMI was associated to greater 30-day DS use (F(1, 285) 
= 3.50, p = .06) and more WLDS use (F(1, 285) = 3.32, p = .07) but did not reach 
statistical significance (Table 4).  
Logistic regression analyses were performed to look at effects of 30-day DS use 
on ephedrine use, steroid use and steroid use intent by gender. DS use was associated 
with intention to use steroids for both males and females. Every 1-unit increase in the DS 
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use score increased the risk to intend on using steroids by 2% in males (OR=1.02, p < 
.001, 95% CI: 1.01-1.02), and 3% in females (OR=1.03, p = .001, 95% CI: 1.01-1.06). 
The multiple logistic regression model looking at the likelihood of steroid use intent was 
not significant for any of type of DS.  
DS use was associated with lifetime use of ephedrine for both males and females. 
There was a 2% increase risk to have used ephedrine in their lifetime per 1-unit increase 
in DS use scores for males (OR=1.02, p = .005, 95% CI: 1.01-1.03), and 3% for females 
(OR=1.03, p = .006, 95% CI: 1.01-1.05). The multiple logistic regression model looking 
at the likelihood of ephedrine use showed that for males, every 1-unit increase in EEDS 
use scores increased the chance of ephedrine use in their lifetime by 17% (OR=1.17, p = 
.02 95% CI: 1.03-1.33). There were no significant associations between the different DS 
types and ephedrine use in females. 
Only 2.4% of males reported having used AAS in their lifetime, while no female 
reported AAS use. Logistic regression models looking at the effect of 30-day DS use as a 
risk factor for AAS use were not significant for either gender (data not shown). 
H1B: There are significant gender differences in scores on body image, which will have 
an effect on physical activity, DS use, ephedrine use, steroid use, and intent on using 
steroids in the future. 
 Figure 3 shows the CDRS scores for body ideal (X) against scores for body size 
(Y) for males and females. The overall average CDRS discrepancy score for body 
dissatisfaction was 1.53 ± 2.98 (range –16 to +16). The mean discrepancy or 
dissatisfaction CDRS score was 2.50 ± 2.22. Satisfaction with body image (CDRS score 
= 0) was similar for males (51%) and females (49%). However, as shown in Figures 3, 
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females showed higher levels of body dissatisfaction, scoring significantly higher than 
males on CDRS magnitude scores (t(659) = -4.97, p < .001). Only 8.2% percent of 
females wanted to be bigger, while 47.9% of the males wanted to be thinner. Figure 4 
shows the distribution of CDRS discrepancy scores for males and females. In addition, of 
those who had a desire to be bigger, 75.4% were male. Of those who had a desire to be 
smaller, 68.8% were female.  
Greater body dissatisfaction (CDRS magnitude scores) predicted lower levels of 
total PA in males (t(1, 280) = -2.53, p = .01) and females (t(1, 377) = -1.99, p = .05). In 
other words, those who exercised less were less satisfied with their body image. When 
looking specifically by gender and type of PA (i.e. aerobic vs weight lifting), greater 
CDRS magnitude scores significantly predicted lower weight lifting in males (t(1, 280) = 
-2.61, p = .01), and lower aerobic physical activity in females (t(1, 377) = -2.06, p = .04). 
 Logistic regression analyses were performed to look at effects of body image on 
ephedrine use, steroid use and steroid use intent by gender. In females, every 1-unit 
increase in CDRS magnitude scores increased the chance that they had used ephedrine in 
their lifetime by 57% (OR=1.57, p = .003, 95% CI: 1.17-2.11). Logistic regression 
models looking the effect of body image increasing the likelihood of steroid use and 
steroid use intent were not significant for either gender. Linear regression analysis 
showed that CDRS magnitude scores predicted greater WLDS use in females (t(1, 377) = 
3.17, p = .002) and EEDS use in females (t(1, 377) = 3.05, p = .002). 
H2: DS use, substance use, BMI, PA, participation in a sport and knowing someone who 
uses steroids will increase the risk of someone using steroids in the future. The 
relationships will vary by gender.  
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 In the hierarchical logistic regression (Table 5) predicting AAS use intent, total 
PA, BMI, and gender were entered as predictors in step 1, participating in a sport was 
entered in at step 2, knowing someone who used steroids was entered as a predictor in 
step 3, 30-day substance use was entered as a predictor in step 4 and total DS (i.e., 
GHDS, WLDS, MBDS and EEDS) use was entered as a predictor in step 5. The analysis 
showed that controlling for total PA, BMI, Participation in Sport and current (30-day) 
substance and DS use, males who know someone who use steroids and use EEDS were 
more likely to report intention to use AAS in the future.  
In the first block, gender (p < .001) was a significant predictor of steroid use 
intent, Nagelkerke R2 = .29, χ2 = 79.15, p <.001, OR: 29.48 95% CI: 6.45-134.77. 
Participating in a sport did not contribute significantly to the model, Nagelkerke R2 = .29, 
χ2 = .70, p = .40. In the third block, knowing someone who used steroids increased the 
likelihood of intending on using AAS in the future more than 5 times (Nagelkerke R2 = 
.38, χ2 = 26.62, p <.001, OR: 5.57, 95% CI: 2.57-12.05). In block four, 30-day substance 
use did not contribute to the model, Nagelkerke R2 = .38, χ2 = .80, p = .37. In the fifth 
block, EEDS use significantly increased the risk of steroid use in the future, Nagelkerke 
R2 = .43, χ2 = 14.58, p <.001, OR: 1.04, 95% CI: 1.04-1.12. Total and other individual 
DS use (i.e., GHDS, WLDS and MBDS) were removed from the final model.  
H3: Physical activity will mediate the relationship between DS use and substance use, 
and this relationship will be moderated by body image. The relationships will vary by 
gender. 
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Gender Effect 
A hierarchical linear regression was first used to test the relationship between 
lifetime substance use, total PA, total DS use and CDRS magnitude scores (Table 6). 
Lifetime substance use was considered the dependent variable and total PA, total DS use 
and CDRS magnitude scores were entered as predictors. Total PA (t(3, 645) = 4.07, p < 
.001) and total DS (t(3, 645) = 3.60, p < .001) use were both significant predictors of 
lifetime substance use. CDRS magnitude scores were moderately significant ((t(3, 645) = 
1,94, p = .053) predictors of lifetime substance use, and were therefore excluded from the 
model looking at both genders. Mediation analysis was conducted with total DS use as a 
predictor of lifetime substance use, and total PA entered as the mediator (Figure 5).  
 First, the results of a regression in which total DS use was entered as a predictor 
of lifetime substance use established a direct association of DS use on lifetime substance 
use, c = .02, SE = .003, t(1, 653) = 5.70, p < .001. Second, total DS use was a predictor of 
total physical activity, a = .04, SE = .003, t(1, 653) = 11.60, p < .001. Multiple regression 
analysis showed that physical activity was a predictor of lifetime substance use 
controlling for total DS use, b = .13, SE = .04, t(1, 653) = 3.72, p = .002. In the third step, 
the direct effect of total DS use on lifetime substance use was shown as significant when 
controlling for physical activity, c’ = .01, SE = .003, t(2, 652) = 3.70, p = .002, 
demonstrating partial mediation. The significance of the indirect effect, ab = .005, was 
confirmed using a Sobel test, z = 3.53, p = .0004.  
Males 
A hierarchical linear regression was used to test the relationship between lifetime 
substance use, total PA, total DS use and CDRS magnitude scores in males (Table 6). 
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Lifetime substance use was the dependent variable and total PA, total DS use and CDRS 
magnitude scores were entered as predictors. Total PA (t(3, 272) = 2.48, p = .01) and 
total DS (t(3, 272) = 2.52, p = .01) use were both significant predictors of lifetime 
substance use. CDRS magnitude scores were not significant predictors of lifetime 
substance use, and were therefore excluded from the moderation analysis looking at 
males. Mediation analysis was conducted with total DS use as a predictor of lifetime 
substance use, and total PA entered as a mediator (Figure 6). 
The results of a regression in which total DS use was entered as a predictor of 
lifetime substance use showed a direct effect of DS use on lifetime substance use, c = .02, 
SE = .004, t(1, 279) = 3.67, p = .003. Total DS use was a predictor of total PA, the 
proposed mediator, a = .03, SE = .005, t(1, 279) = 7.02, p < .001. Multiple regression 
analysis showed that physical activity was a predictor of lifetime substance use 
controlling for total DS use, b = .12, SE = .05, t(2, 278) = 2.25, p = .03. The direct effect 
of total DS use on lifetime substance use was significant when controlling for total PA, c’ 
= .01, SE = .005, t(2, 278) = 2.53, p = .012, showing partial mediation. The significance 
of the indirect effect, ab = .004, was confirmed using a Sobel test, z = 2.12, p = .03. 
Females 
A hierarchical linear regression was used to test the relationship between lifetime 
substance use, total PA, total DS use and CDRS magnitude scores in females (Table 6). 
Lifetime substance use was considered the dependent variable and total PA, total DS use 
and CDRS magnitude scores were entered as predictors. CDRS magnitude scores (t(3, 
369) = 2.02, p = .04) and total DS (t(3, 369) = 1.99, p = .05) use were both significant 
predictors of lifetime substance use. Total PA was not significant predictors of lifetime 
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substance use, and was therefore excluded from the mediation analysis looking at 
females. Mediation analysis was conducted with total DS use as a predictor of lifetime 
substance use, and CDRS magnitude scores entered as the mediator (Figure 7). 
The regression analysis showed that total DS use predicted lifetime substance use 
(direct effect), c = 0.01, SE = 0.005, t(2, 370) = 2.88, p = .004. Total DS use was not a 
significant predictor of CDRS magnitude scores (the proposed mediator), a = 0.008, SE = 
0.005, t(1, 371) = 1.70, p = .09, but CDRS scores were conservatively maintained in the 
model. The direct effect of total DS use on lifetime substance use was also significant 
when controlling for physical activity, c’ = 0.01, SE = 0.005, t(2, 370) = 2.72, p =.007.  
DISCUSSION  
This study sought to explore the relationship between current dietary supplement 
use and use of other substances including APED, steroids, and other substances. We also 
examined the role physical activity, gender, and BMI on the relationship between the use 
of DS and other substances.  
Compared to females, males reported higher use of all four types of dietary 
supplements (i.e., general health, weight loss, muscle building and energy enhancing) as 
well as more current and lifetime use of substances. Further, energy enhancing dietary 
supplement use specifically increased the likelihood of ephedrine use in males. This is 
comparable to a study done by Backhouse, et al. (2013), which showed that dietary 
supplement users were more open to the use of substances banned by the World-Anti-
Doping Agency.  
While the link between dietary supplement use and AAS use has been seen in 
other studies (Hildebrandt, et al., 2010; Yager & O’Dea, 2014; Backhouse, et al., 2013; 
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Hoffman, et al., 2008; Buckman, et al., 2013), DS use was not related to steroid use in 
our sample. However, dietary supplement use increased the risk of intention to use 
steroids in the future and increased the likelihood of having used ephedrine for both 
males and females. Specifically, male EEDS users who know someone who use steroids 
were more likely to report intention to use AAS in the future. These findings suggest that 
there may be common underlying factors motivating young adults to engage in both 
dietary supplement use and illegal and dangerous APED use; in particular, males seem 
more likely to engage in dangerous behaviors, putting themselves at high risk for 
negative health and legal consequences related to substance abuse. The fact that dietary 
supplement use was not associated with previous AAS use in this sample may have been 
due to the fact that such a small number of participants (1%) reported AAS use. Findings 
in the literature regarding DS use by gender have been inconsistent, with higher use 
among young males reported by some researchers (Marques-Vidal, 2004; Bell, Dorsch, 
McCreary, & Hovey, 2004); but not all (Sotoudeh, et al, 2015; Wardenaar, van den Dool, 
Ceelen, Witkamp, & Mensink, 2016; Sundgot-Borget, Berglund, & Torstveit, 2003; 
Bailey et al., 2013; Knapik et al., 2013).  
Females using more dietary supplements report the primary reason to be a desire 
to improve or maintain their health Sotoudeh, et al, 2015; Wardenaar, van den Dool, 
Ceelen, Witkamp, & Mensink, 2016; Sundgot-Borget, Berglund, & Torstveit, 2003; 
Bailey et al., 2013; Knapik et al., 2013), while males report using DS in order to increase 
power, endurance, and increase muscle size (Giannopoulou, et al., 2013).  
Interestingly and congruent with the body image of females, BMI was a 
significant predictor of use of weight loss dietary supplement in females, even though 
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more than half (66%) of females who admitted to using weight loss dietary supplements 
had a BMI below 25 (i.e. healthy weight or underweight). Also consistent with the 
literature, BMI predicted use of energy enhancing dietary supplements in males 
(Wardenaar, et al, 2016; McDowall, 2007).  
Consistent with previous research, satisfaction with body image was similar for 
males (51%) and females (49%). However, also consistent with previous research, 
females showed higher levels of body dissatisfaction and a desire to be smaller. As it has 
been shown before, few females (8.2%) wanted to be bigger, while males wanted to be 
both thinner and more muscular (Furnham, Badmin & Sneade, 2002; Bucchianeri, 
Arikian, Hannan, Eisenberg & Neumark-Sztainer, 2013). A greater dissatisfaction in 
body image predicted lower rates of physical activity in both genders. Specifically, 
greater dissatisfaction in body image predicted less weight lifting activity in males and 
showed a moderately significant, negative association with aerobic physical activity in 
females. Negative body image did not seem to be related to dangerous exercise behaviors 
in the young adults in our sample. The inverse relationship between the two variables 
suggest that physical activity may instead act as a protective factor. These results differ 
from findings of other studies looking at gender differences on the effects of negative 
body image on a drive for muscularity in males, which leads to more muscle enhancing 
behaviors (Kelley, et al., 2010; Arbour, & Martin-Ginis, 2005; Cramblitt & Pritchard, 
2013; Peixoto-Labre, 2002; Eisenberg, et al., 2012) and on a drive for thinness in 
females, which leads to dangerous weight loss behaviors (Boepple & Thompson, 2016; 
Kelley, et al., 2010; Prichard & Tiggemann, 2007). The differences between previous 
studies and the results of the present study may be due to our recruitment strategy. 
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Students in our sample might be body-conscious individuals who exercise more often, 
and may be more satisfied with their appearance because they are actively engaged in 
achieving their fitness and appearance goals (Davis, Elliott, Dionne & Mitchell, 1991; 
Davis & Cowles, 1991). This argument would also explain why the relationship between 
body image and exercise type varied by gender. Males who are actively engaged in 
achieving the muscular body ideal must participate specifically in muscle building 
exercise, while females should participate in aerobic exercise to achieve a thin body ideal 
(Davis & Cowles, 1991), hence these behaviors can actually lead to greater body 
satisfaction (Davis, et al., 1991). 
An increase in body image dissatisfaction increased females’ risk of using 
ephedra in their lifetime, and was associated with greater use of weight loss and energy 
enhancing dietary supplements. Ephedra is a central nervous system stimulant that is 
often used to aid in weight loss or performance enhancement (McDuff & Baron, 2005; 
Hildebrandt, 2007), therefore the results show a clear relationship between negative body 
image and weight-loss related APED use in females. Similarly, Piexoto-Labre (2002) 
argued that Social Comparison Theory motivates young males to utilize images of males 
in the bodybuilding industry as socially desirability indices, later leading them to engage 
in extreme behaviors to obtain their desired body type.  
Although much of the research on the dangers of the fitness industry on body 
image focuses on exposure to media (Peixoto-Labre, 2002; Peixoto-Labre, 2004; Arbour, 
& Martin-Ginis, 2005; Cramblitt & Pritchard, 2013; Shoger, 2008; Krawiec, 2016; 
Boepple & Thompson, 2016), this study instead used physical activity, participation in a 
sport, knowing someone who uses steroids and current DS use as measures of potential 
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risk factors. In this sample, 15% of males and 0.5% of females reported they intended on 
using steroids in the future.  Gender, dietary supplement use, specifically energy 
enhancing supplement use, and knowing someone who used steroids were significant 
predictors of intent to use steroid in the future. These results are consistent with previous 
research (Dun et al., 2009) showing that male weightlifters were more likely to use AAS 
if they had a close friend who used AAS. Social Cognitive Theory explains how the 
participants in this study may have been influenced by the actions of others in the fitness 
industry through social prompting (Bandura, 2001; Bandura, 2002). A mentioned earlier, 
there seems to be an underlying link between illegal APED use and dietary supplement 
use. Exposure to the fitness culture and the extreme body types promoted by this industry 
may be increasing both dietary supplement use and AAS use. 
Unlike previous research which suggests athletes are at a higher risk of steroid use 
(Sundgot-Borget, et al., 2003), participating in a sport was not a significant predictor of 
intentions to use AAS. While the pressure to perform may have still put the athletes at a 
higher risk to use AAS (Ehrnborg & Rosen, 2009; Wood, 2008), these students may have 
been less likely to use AAS due to regular drug testing performed by the team, as well as 
greater access to education on the dangers of AAS use through coaches or trainers. These 
results also suggest that college students may be using DS for aesthetic, as opposed to 
performance – related, purposes.  
The results also varied from previous research looking at the relationship between 
steroid and other substance use (DuRant, Escobedo & Health, 1995; Buckman, et al., 
2013; McDuff & Baron, 2005; McCabe, et al., 2007; Kanayama, Pope, Cohane, & 
Hudson, 2003; Raevuori, et al., 2006) in that current substance use was not a significant 
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predictor of steroid use intent. This difference may have been because AAS users may 
use more of a specific drug that may improve performance, such as amphetamines or 
cocaine (Dunn, et al., 2009) as opposed to all types of substances. This argument is 
strengthened by the fact that only the use of energy-enhancing dietary supplements, 
which have similar properties to drugs such as amphetamine (Eudy, et al., 2013), 
increased the risk of future AAS use.  
Physical activity partially mediated the relationship between current dietary 
supplement use and lifetime substance use. Contrary to our hypothesis, body image did 
not moderate this relationship when looking at both genders. When looking at males, 
physical activity partially mediated the relationship between current dietary supplement 
use and lifetime substance use; body image was not at all related to substance use. 
However, the opposite was seen in females; dietary supplement use and body image, not 
physical activity, were significant predictors of substance use. It is important to note that 
some studies show a negative relationship between substance use and dietary supplement 
use (Bailey, et al., 2013; Dickinson & MacKay, 2014) as well as physical activity and 
substance use (Pate, Heath, Dowda, & Trost, 1996; Kwan, Bobko, Faulkner, Donnelly & 
Cairney, 2014; Delisle, Werch, Wong, Bian & Weiler, 2010; Dickinson & MacKay, 
2014). Similar gender differences were reported by Sotoudeh et al. (2003), who showed 
that dietary supplement use was related to physical activity in males but not females. 
These results may be due to differences in the types of physical activity performed by 
males as opposed to females, as well as gender differences in the types of dietary 
supplements most commonly used by each gender. 
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LIMITATIONS 
 This study was based on self-reported data rather than direct observation. Causal 
relationships cannot be determined due to the cross sectional design of the study. There 
were significant differences in steroid use, ephedrine use, steroid use intent and knowing 
someone who used steroids between those who replied to questions about drug use and 
those who selected “prefer not to answer”. Although the survey was anonymous, 
participants may have chosen not to answer questions about drug use due to the social 
desirability effect. The length of the survey may have also contributed to participants’ 
choice to select “prefer not to answer”.  
Young adults are motivated to seek a certain look through images provided by 
popular media. This study aimed to look at the relationship between the various actions 
that have been shown to stem from viewing this media. Future research should also 
measure exposure to various forms of media focused on the fitness industry in either a 
natural setting (ex: asking about how many social media platforms they use, how often 
they use them, and what percentage of the content on these platforms is fitness related) 
and in a lab-based setting (ex: asking participants to engage with fitness-related media 
and measuring the effects of this exposure).  
Future research should also ascertain the students’ health status and possible side 
effects experienced due to dietary supplement use. While participants were given a list of 
commonly used dietary supplements, future studies could include an open-ended section 
in order to capture substances that are either banned by the FDA or have known side 
effects.  
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Low scores on substance use may be due to the fact that many students who begin 
using hard drugs such as heroin or cocaine are more likely to drop out of school and 
would therefore be excluded from our sample; future samples should include participants 
outside of the academic setting. 
CONCLUSION 
 The evidence from this study shows a connection between dietary supplement use 
and other dangerous health behaviors, including current and future illegal APED use and 
other substance use. The high prevalence of DS use, the availability of supplements with 
a high nutrient content, and the risk of multi-substance use make this a concern for the 
long term health of the students. This trend highlights the need to develop educational 
programs to inform young adults about the potential risks and benefits of DS use and 
misuse. 
Physical activity seems to act as both a protective factor and risk factor for these 
dangerous behaviors, and clear gender differences emerge along the lines of body image 
theories, specifically the drive for thinness in females and the drive for muscularity in 
males. Future research should also explore strategies to address the complex issues of 
body dissatisfaction among young adults as well as interventions to promote healthy 
living. 
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In order to participate in this study, you must be between the ages of 18 and 34, and 
participate in regular physical activity at the Sun Devil Fitness Center at least once per 
week (outside of your regular job or house work). 
 
The survey will take about 45 minutes to complete. Completing the survey will give you 
a chance to win 1 of 52 $10 electronic VISA gift cards. After completing the survey, you 
will be redirected to a separate SurveyMonkey page, where you will fill in your contact 
information, and will be entered into an online raffle. Your contact information will not 
be connected to your answers in the survey. If you are a winner in the raffle drawing, 
your gift card will be emailed to you by the end of the Fall 2016 Semester. 
 
Your participation in this anonymous survey is completely voluntary. If you chose to 
withdraw at any time, you may do so without penalty. You may also refuse to answer 
questions that make you uncomfortable. Some questions ask about illegal activities, such 
as illegal drug and alcohol use, and steroid use. By participating in this study, you are 
helping us to learn about young adults’ health-related behavior as well as possible risk 
and protective factors including physical activity (i.e., level, pattern and routine), 
knowledge and consumption of dietary supplements and other substances, sleep quality, 
and self-image. All of this information may be used to create a program to improve the 
health of students.  
 
After completing the survey, you will find some additional information about the study. 
You may request a copy of the study results, noting that results may not be analyzed until 
a few months after the survey is closed. Participants’ personal information will not be 
used in any presentations or publications resulting from this study. 
Filling out the survey will be considered your consent to participate.  
If you have any questions, please contact me Agnes Bucko by email at abucko@asu.edu 
or Dr. Perla Vargas at Perla.Vargas@asu.edu or 602-543-8224. If you feel this study has 
placed you at risk, or if you have questions about your rights as participant in this 
research. Please contact the Chair of the Human Subjects Institutional Review Board, 
through the office of Research Integrity and Assurance, at (480) 965-6788  
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Differences in scores on 30 day and lifetime substance use scores for variables missing 
data 
Variable 30 day substance use 
score 
t-score Lifetime substance use 
score  
t-score 
 Missing Not Missing  Missing Not Missing  
Lifetime 
ephedrine 
use 
 
 
0 
 
 
9.88 ± 7.30 
 
 
2.27+ 
 
 
0 
 
 
5.87 ± 4.19 
 
 
2.35+ 
Lifetime 
steroid use 
 
0 
 
8.17 ± 5.12 
 
2.14 
 
0 
 
5.83 ±  4.07 
 
1.92 
Steroid use 
intent 
 
1.60 ± 3.03 
 
7.43 ± 7.78 
 
2.32+ 
 
1.70 ± 2.21 
 
4.22 ± 3.04 
 
2.47+ 
Know 
someone 
who uses 
steroids 
 
 
 
1.50 ±3.67 
 
 
 
6.41 ± 7.52 
 
 
 
1.59 
 
 
 
1.00 ± 1.55 
 
 
 
3.76 ± 3.25 
 
 
 
2.07+ 
Note:  **p < .001, *p < .01, +p < .05; Missing ephedrine use n = 3; Missing steroid use n 
= 2; Missing steroid use intent n = 10; Missing knowing someone who uses steroids n = 6
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APPENDIX D 
TABLE 2 
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Differences (t-test) in Demographic characteristics, BMI, physical activity, and substance 
use (DS, AAS, and substance) by gender (N = 680) 
Variable All 
(M and SD) 
Females 
N = 380 
(M and SD) 
Males 
N = 287 
(M and SD) 
t-test 
Age 20.57 ± 2.77 20.17 ± 2.47 21.10 ± 3.05 4.38** 
BMI 23.76 ± 4.52 23.38 ± 4.85 24.26 ±3.99 2.49* 
- % Underweight 6.4 8.2 4.2  
- % Normal weight 61.8 65.8 56.4  
- % Overweight 24.4 18.9 31.7  
- % Obese 7.3 7.1 7.7  
Hours spent WL / week 2.80 ± 3.04 1.86 ± 2.30 4.05 ± 3.44 9.87** 
- % WLPA 64.2 55.3 76  
Hours spent AE / week 0.88 ± 0.77 0.80 ± 0.65 0.98 ± 0.90 2.94* 
- % AEPA 100 100 100  
Hours spent total PA / week 3.68 ± 3.25 2.66 ± 2.47 5.03 ± 3.64 10.00** 
- % Total PA  100 100 100  
% Participate in organized 
sports team 
 
15.6 
 
11.6 
 
20.9 
 
30-day DS use score 17.48 ± 35.00 11.08 ± 28.79 25.95 ± 41.26 5.55** 
% 30-day DS use  30.1 20.3 43.2  
- GHDS  8.19 ± 19.65 5.95 ± 17.02 11.17 ± 22.36 3.42** 
- WLDS 1.64 ± 4.34 1.14 ± 3.57 2.31 ± 5.11 3.46** 
- MBDS 4.30 ± 9.15 1.92 ± 5.33 7.45 ± 11.83 8.09** 
- EEDS 3.34 ± 6.62 2.07 ± 5.35 5.03 ± 7.79 5.81** 
- % GHDS  28.8 20.0 40.4  
- %WLDS  23.1 16.3 32.1  
- % MBDS 27.6 16.8 41.8  
- % EEDS 28.5 19.2 40.8  
30-day substance use score 4.07 ± 5.89 3.26 ± 4.83 5.16 ± 6.92 4.15** 
% 30-day substance use  59.7 57.8 62.3  
Lifetime substance use score 2.66 ± 2.80 2.22 ± 2.47 3.25 ± 3.10 4.72** 
% lifetime substance use  66.4 62.8 71.2  
Have used AAS  1.0 - 2.4  
Have used ephedrine  1.3 0.5 2.4  
Intend on using steroids in 
future 
 
6.9 
 
0.5 
 
15.3 
 
Know someone who uses 
AAS 
 
27.6 
 
23.4 
 
33.1 
 
Note:  **p < .001, p < .01; BMI – Body Mass Index; WL - Weight Lifting, AE – Aerobic 
Exercise, PA – Physical Activity, DS – Dietary Supplement, AAS - Anabolic-Androgenic 
Steroids, GHDS – General Health Dietary Supplement; WLDS – Weight Loss Dietary 
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Supplement; MBDS – Muscle Building Dietary Supplement; EEDS – Energy Enhancing 
Dietary Supplement
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APPENDIX E 
TABLE 3 
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Correlations for variables in Hypothesis 1 
Variable 1 2 3 4 5 6 7 
Total physical activity        
BMI .03       
Gender -.36** -.10+      
Lifetime steroid use .11** .10+ -.12*     
Lifetime ephedrine use .09† .07 -.08† .24**    
Steroid use intent .25** .06 -.30** .03 .07   
Total DS use score .41** .08† -.21** .12 .21** .33**  
CDRS magnitude -.17** .37** .18** -.01 .10* -.05 -.02 
Note: **p < .001, *p < .01, †p < .05; BMI – Body Mass Index 
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Linear regression for BMI predicting DS use  
 Male Female 
 Total 
DS 
GHDS WLDS MBDS EEDS Total 
DS 
GHDS WLDS MBDS EEDS 
B 1.14 0.51 0.14 0.22 0.27 0.13 0.01 0.09 -0.05 0.07 
SE B 0.61 0.33 0.08 0.17 0.12 0.29 0.18 0.04 0.06 0.06 
β 0.11 0.09 0.11 0.08 0.14 0.02 0.003 0.12 -0.04 0.07 
t 1.87 1.55 1.82 1.28 2.32 0.43 0.05 2.43 -0.82 1.28 
p .06 .12 0.07 .20 .02† .67 .96 0.02† .41 .20 
F 3.50 2.40 3.32 1.63 5.36 0.17 0.003 5.89 0.67 1.65 
Note: †p < .05; B – y-intercept; SE B – Standard error of y-intercept; β – Beta; The 
following are outcome variables: DS – Dietary Supplement; GHDS – General Health 
Dietary Supplement; WLDS – Weight Loss Dietary Supplement; MBDS – Muscle 
Building Dietary Supplement; EEDS – Energy Enhancing Dietary Supplement 
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APPENDIX G 
TABLE 5 
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Hypothesis 2 – Hierarchical multiple logistic regression for intention to use AAS. 
  95% CI for OR  
 Adjusted OR Lower Upper Sig 
Step 1     
Total PA 1.06 0.96 1.17 .23 
BMI 0.97 0.88 1.07 .49 
Male gender 29.48 6.45 134.77 <.001 
Step 2     
Participation in Sport 1.55 0.69 3.52 .29 
Step 3     
Know someone who 
uses steroids 
 
5.57 
 
2.57 
 
12.05 
 
<.001 
Step 4     
30 day substance use 0.99 0.95 1.05 .91 
Step 5     
EEDS use  1.08 1.04 1.24 <.001 
Note: **p < .001; B – y-intercept; SE B – Standard error of y-intercept; β – Beta. OR – 
Odds Ration, CI Confidence Interval, PA – Physical Activity, BMI – Body Mass Index, 
AAS - Anabolic-Androgenic Steroids, EEDS – Energy Enhancing Dietary Supplement 
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Linear regression measuring predictors of lifetime substance use including physical 
activity, DS use and body dissatisfaction as measured by the CDRS 
Variable B SE B β t p df 
Total PA 0.15 0.04 0.17 4.07 < .001 3, 645 
Total DS use 0.01 0.003 0.15 3.60 < .001 3, 645 
CDRS 
magnitude 
 
0.09 
 
0.05 
 
0.08 
 
1.94 
 
.053 
 
3, 645 
Males       
Total PA 0.14 0.06 0.16 2.48 .01 3, 272 
Total DS use 0.01 0.005 0.16 2.52 .01 3, 272 
CDRS 
magnitude 
 
0.14 
 
0.103 
 
0.08 
 
1.37 
 
.17 
 
3, 272 
Females       
Total PA 0.09 0.06 0.09 1.62 .11 3, 369 
Total DS use 0.01 0.005 0.11 1.99 .05 3, 369 
CDRS 
magnitude 
 
0.11 
 
0.05 
 
0.11 
 
2.02 
 
.04 
 
3, 369 
PA – Physical activity; DS – Dietary Supplement; CDRS – Contour Drawing Ratings 
Scale; B – y-intercept; SE B – Standard error of y-intercept; β – Beta
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APPENDIX I 
FIGURE 1 
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Image from 2017 issue of Muscle and Fitness 
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APPENDIX J 
FIGURE 2 
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Contour Drawing Ratings Scale (CDRS) 
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APPENDIX K 
FIGURE 3 
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Scatter plot of CDRS scores of body ideal (Y) against body size for males and females 
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APPENDIX L 
FIGURE 4 
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Distribution of CDRS scores by percentage for males and females 
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APPENDIX M 
FIGURE 5 
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Physical activity mediating the relationship between DS use and lifetime substance use in 
both genders 
 
 
 
 
 
 
 
 
 
 
 
 
Lifetime 
substance use  
Total PA 
Total DS use  
a = 0.04, p < .001  b = 0.13, p = .002 
c = 0.02, p < .001 /  
c’ = 0.01, p = .002 
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FIGURE 6 
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Physical activity mediating the relationship between DS use and lifetime substance use in 
males 
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c’ = 0.01, p = .012 
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APPENDIX O 
FIGURE 7 
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CDRS magnitude mediating the relationship between DS use and lifetime substance use 
in females 
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Total DS use  
a = 0.008, p = .09  b = 0.09, p = .07 
c = 0.01, p = .004 /  
c’ = 0.01, p = .007 
